SEEING THAT PALMETTO, GBA, the nation’s largest Medicare Administration Contractor, seems to be at the center of the controversy over how Medicare is to pay for molecular pathology (MoPath) tests, THE DARK REPORT sent a list of questions to Palmetto Vice President Mike Barlow. Here are the questions and his answers. Q: Is it true […]
- "MoPath Pricing Update"
Palmetto: ‘We Are Processing & Paying Clean Claims without Undue Delay’
Medicare contractor says it established gap-fill pricing on January 31 and any delay to labs ‘was minimal’
- By Robert Michel
- > From the Volume XX No. 5 - April 15, 2013 Issue
